Specialist hedge fund RessCapital builds consistent gains with esoteric life settlements strategy (by Hugh Leask, Hedgeweek)
RessCapital, a specialist boutique hedge fund manager, is generating consistent uncorrelated returns with a novel investment strategy that focuses on the US life insurance industry.
The Stockholm-based shop’s Ress Life Investment fund invests in the secondary market for US life insurance policies, where products no longer required by individual policyholders can be offloaded to third party brokers and brought to market to be traded at a discount. Jonas Mårtenson, the firm’s founder and head of sales, established RessCapital in 2006, initially focusing on real estate, later switching to the more novel life insurance secondary market about a decade ago.
Established in 2011, the Ress Life Investments fund – which today manages around USD185 million in assets – has notched up positive returns in seven of the last nine years, and has outperformed its 7 per cent annual target in four of the last five years.
“It’s not linked to the economic cycle in any way,” Jonas Mårtenson, the firm’s founder and head of sales, says of the strategy’s track record, which includes a near 10 per cent return in 2018, followed by a 7.9 per cent gain last year – its most successful years to date. “Mortality is not linked to how equity markets perform. This is what made me interested.”
He continues: “Uncorrelated returns can be difficult to find in various alternative investments – a lot of hedge funds claim they deliver it, but often when we have a strong correction everything tends to go down at the same time, as we saw in March.”
RessCapital’s portfolio typically comprises around 300 life policies, issued by a diverse pool of about 50 US-based life insurers, which it will then typically buy-and-hold until the existing policies pay out.
The investment approach is built around a proprietary portfolio management model which involves longevity calculations on each individual policy in order to determine pricing and anticipated returns on assets.
Specifically, this involves deep-dive analysis from independent medical underwriters on the policy prior to RessCap taking the position, with portfolio risks and limits – determined by issuer, life expectancy, age group, among other things – continually monitored.
The average policyholder age in the portfolio is 79 years, and the fund favours less risky policies held by wealthy individuals who are in good health with lower premiums, Mårtenson explains. More than 90 per cent of the fund’s assets are policies issued by insurers with credit ratings of A or above.
“We filter out about 97 per cent of the policies we look at,” he adds. “We buy only a few. It’s a very OTC, very administrative-intensive market, and we are cherry-picking the best policies.”
The total outstanding volume of life insurance in the US is around USD20.5 trillion, with the secondary market sized between USD4 billion and USD5 billion.
“Everyone owns a life insurance policy in the US, with many people owning perhaps more than one policy,” Mårtenson says. “Nine out of 10 policies lapse – they never pay out – and life insurance firms know this. But why should someone who’s 78 years old, whose children have grown up, and whose wife may have passed away, still be paying all these life insurance premiums when he doesn’t need it anymore?”
Rather than let it lapse, various insurance brokers can bid on the policy in an open market, with the holder potentially being paid 10 times more than surrendering the policy – a “win-win situation” for the individual, according to Mårtenson.
The fund is down slightly so far this year at -0.16 per cent. But despite the ongoing coronavirus pandemic, the secondary and tertiary market for US life insurance policies has continued to function. While the Covid-19 outbreak will see mortality rise, the pandemic is not impacting the fund’s performance negatively, according to Mårtenson, since the strategy’s exposure tends to be towards healthier, better-off policyholders who are comparatively less affected by the virus.
He maintains the strategy offers attractive, risk-adjusted uncorrelated returns for investors. “Our investors already own equities, bonds, property. This is something completely different,” he explains, noting how the fund’s three largest investors account for less than 10 per cent of the investor base. “We bring risk diversification for them. We view this asset class as being similar to alternative fixed income. If we can deliver 7 per cent annually with 4 per cent volatility, it’s pretty attractive for investors.”
Access to the article at Hedgeweek here or below
RessCapital_article_Hedgeweek_2020
About Resscapital
Resscapital AB is an alternative investment fund manager (AIFM) authorised and regulated by the Swedish Financial Services Authority (Finansinspektionen).
We have since 2011 bought a diversified life insurance portfolio on behalf of Ress Life Investments, which is listed at Nasdaq Copenhagen. Proprietary portfolio management systems and pricing models have been developed. The company also collaborates with independent medical underwriters specialising in senior mortality.
The management team has complimentary backgrounds and international experience from having worked at major banks, institutional investors and hedge funds. The board of directors consists of both successful entrepreneurs and senior managers with extensive experience from the financial industry.
See here for more news from Resscapital AB
Attractive Long-Term Returns
Ress Life Investments A/S purchases US life insurance policies in the secondary market. The company owns a diversified portfolio and policies are issued by over 50 highly rated US life insurance companies. The investment objective is to provide attractive uncorrelated returns in USD over the long-term. Ress Life Investments is listed at Nasdaq Copenhagen since 2015.
Attractive risk-adjusted return – the target return is 7% per annum in USD without any leverage.
Low volatility – a well-diversified life insurance portfolio offers investors stable and attractive risk-adjusted returns. Monthly historical volatility during the last five years is 4%.
Risk diversification – the return profile of the life insurance portfolio is characterised by low correlation to other asset classes, which makes the strategy attractive for investors seeking risk diversification.
Exchange-traded – the company is listed at NASDAQ Nordic and a market-maker provides daily prices.
Ress Life Investments A/S is a limited liability company incorporated in Denmark. The company is an alternative investment fund (AIF) managed by Resscapital AB, a limited liability company incorporated in Sweden. Resscapital AB is authorised as an alternative investment fund manager (AIFM) and supervised by Finansinspektionen, the Swedish Financial Supervisory Authority.
The depositary for Ress Life Investments A/S is Artha Fondsmaeglerselskab A/S. The administrator is Citco Denmark ApS, which is part of the Citco Group. The independent board consists of four members with extensive experience from the financial markets. Ress Life Investments A/S is audited annually by Deloitte.
Ress Life Investments A/S is admitted to trading and official listing on NASDAQ Copenhagen. The company’s short name is RLAINV, ISIN DK0060315604. Current share prices can be found under the segment – Alternative Investment Funds on NasdaqOMXNordic.
Danish and Swedish retail investors and professional/accredited investors may also subscribe for shares on a monthly basis at the company’s current net asset value per share.
